MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$642,090
Deferred revenue
$112,261
Income tax payable
$79,030
Accrued expenses
$1,964
Net cash provided by
operating activities
$172,178
Canceled cashflow
$663,167
Net increase in cash
-$592
Canceled cashflow
$172,178
Advances from related
parties
$3,046,080
Accounts receivable
$298,972
Inventory
$278,029
Lease cost, net of
repayments
$61,236
Prepaid expenses
$16,509
Deposits
$4,400
Deferred tax
$2,069
Accounts payable
-$1,952
Net cash provided by
financing activities
-$115,920
Canceled cashflow
$3,046,080
Purchase of intangible
assets
$56,850
Repayment to related
parties
$3,162,000
Back
Back
Cash Flow
source: myfinsight.com
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)